Patented Medicine Prices Review Board

The Patented Medicine Prices Review Board (PMPRB) protects and informs Canadian consumers by ensuring that the prices of patented medicines sold in Canada are not excessive, and by reporting on pharmaceutical trends.

We are an independent quasi-judicial body that is part of the Health portfolio, and operate at arm’s-length from the Minister of Health.

We are in the process of moving our services and information to Canada.ca.

Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.

Follow:

Latest

Promotions

Our services and information

New patented medicines reported to the PMPRB

Search for new patented medicines reported to the PMPRB by keyword, status, and/or year reported.

Regulatory process

Find information on the PMPRB’s regulatory and investigative process.

Are you a patentee?

Find information on the PMPRB’s statutory reporting requirements, guidance on filing requirements and deadlines for patentees, outreach presentations and recorded Webinar sessions, and answers to frequently-asked questions.

Reports and trends

Find information on key trends in sales and prices of patented drug products, and in drug manufacturers’ investments in pharmaceutical research and development.

The Hearing process

Find information on the PMPRB’s hearing process, the status of ongoing proceedings, and a listing of Board decisions and orders.

What we are doing

Features

Regulating prices

The Patented Medicine Prices Review Board is responsible for ensuring the prices that patentees charge for prescription and non-prescription patented medicines sold in Canada to wholesalers, hospitals, pharmacies or others, for human and veterinary use, are not excessive.

Pharmaceutical trends

The Patented Medicine Prices Review Board reports annually to Parliament through the Minister of Health on its price review activities, the prices of patented medicines and price trends of all prescription drugs, and on the research-and-development expenditures reported by pharmaceutical patentees.

National Prescription Drug Utilization Information System (NPDUIS)

The National Prescription Drug Utilization Information System (NPDUIS) is a research initiative jointly conducted by the Patented Medicine Prices Review Board and the Canadian Institute for Health Information. NPDUIS provides policy-makers and drug plan managers with information and insight on trends in pharmaceutical prices, use, and costs.

Corporate information

Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: